Vaginal surgery for pelvic organ prolapse
ProcedureVaginal surgery of any vaginal compartment for pelvic organ prolapse
NCT Number: NCT07628036
Surgical correction of pelvic organ prolapse (POP) may be associated with the development of postoperative stress urinary incontinence (SUI). This clearly affects women's satisfaction and their quality of life, and may require subsequent medical and/or surgical treatments.
On the other hand, pre-existing SUI could resolve after corrective prolapse surgery. Similarly, urge urinary incontinence (UUI) could appear or improve after vaginal POP surgery. Therefore, it is of paramount importance to know the prevalence of urinary incontinence after POP vaginal surgery and incontinence resolution in our population. Identifying the risk factors for the development of urinary incontinence may allow to provide individualized treatment.
Trial opening soon.
Get Notified18 year–99 year
Female
Observational
Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vaginal surgery of any vaginal compartment for pelvic organ prolapse
Time frame: 1 year after surgery.
Time frame: 1 year after surgery
Time frame: 1 year after surgery
Time frame: 1 year after surgery
Contact information is provided by the study sponsor or research team.
Hospital Universitari Vall d'Hebron Research Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07271862
Female Sexual Dysfunction (FSD), Female Urogenital Diseases
Riga, Latvia
View Trial DetailsNCT07600697
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Los Angeles, California, United States
View Trial DetailsNCT06848634
Behavior, Chronic Pelvic Pain
View Trial DetailsNCT07430865
Bowel Symptoms, Female Urogenital Diseases
Gothenburg, Sweden
View Trial Details